CDH2 and neoplasm: Another key driver of tumor invasiveness is cadherin dysregulation, whereby downregulation of E-cadherin and upregulation of N-cadherin disrupt cell-cell adhesion and promote tumor spread through epithelial-mesenchymal transition (EMT) [4].